24 Hrs
Source:
The Boston Globe
_1777370220974_847775619.png&w=48&q=75){kind=small}
Challenges in selling parental embryo data
The article discusses the rapid expansion of commercial reproductive technologies, particularly preimplantation genetic testing (PGT), used in conjunction with IVF to select embryos based on genetic information. It highlights concerns about the ethical, social, and health implications of marketing embryo selection for complex traits and disorders, the potential moral obligation imposed on prospective parents, and the risks of undermining social solidarity and human diversity. The piece calls for increased regulation and ethical oversight to ensure reproductive choices prioritize health and autonomy without reinforcing social inequalities.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)